Thus, some studies have observed that this molecule is commonly expressed in triple-negative breast cancers (TNBC) [49] and its higher expression is related to a significantly decreased survival and higher tumour grade [50], whereas a more recent study has shown that only 10% of TNBC are positive to PD-L1 [51]. The gene discussed is CD274; the disease is triple-negative breast carcinoma.